Le Lézard
Classified in: Health, Science and technology
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

Goodness Growth Holdings Reschedules Fourth Quarter and Full Year 2023 Results Call to April 1, 2024


MINNEAPOLIS, March 25, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that, due to scheduling conflicts, it has rescheduled its fourth quarter and full year results conference call for the year ended December 31, 2023 to Monday, April 1, 2024 after the market closes.

Goodness Growth management will host a conference call with the investment community that day, Monday, April 1, 2024 at 4:30 p.m. ET (3:30 p.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company's Investor Relations website and via the following link:
https://events.q4inc.com/attendee/669854452.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. Today, the Company is licensed to grow, process, and/or distribute cannabis in four markets and operates 14 dispensaries in three states. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information
   
Investor Inquiries:
Sam Gibbons
Managing Director
[email protected]  
(612) 314-8995
 Media Inquiries:
Amanda Hutcheson
Corporate Communications
[email protected]   
(919) 815-1476




These press releases may also interest you

at 18:35
Teva Pharmaceutical Industries Ltd. today announced that Richard Francis, Teva's President and CEO, will present at the 2024 Bank of America Healthcare Conference on Tuesday, May 14, 2024. The presentation will begin at 8:40 A.M. Pacific Time (11:40...

at 18:25
The Wiland, Inc. Board of Directors today announced that Mike Gingell has been named the new CEO of Wiland, Inc. This appointment, effective April 29, helps fulfill the Board's commitment to building a strategic leadership team whose competencies and...

at 18:23
President of Xinhua News Agency Fu Hua and Hungarian Minister for National Economy Marton Nagy pledged here on Thursday to enhance media cooperation to contribute to bilateral ties. During his meeting with Nagy, Fu highlighted the robust cooperation...

at 18:00
Tachyus announced a new contract today with Grayson Mill Energy (GME) for Aurion, its cloud-scalable, integrated GHG emissions management platform. Using Aurion, GME will be able to evaluate the impact of future operational plans, like field...

at 18:00
Nektar Therapeutics will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review...

at 17:45
ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or...



News published on and distributed by: